FDA Inspection 928478 — S&B Pharma LLC d.b.a. Norac Pharma

S&B Pharma LLC d.b.a. Norac Pharma — FEI 2015729

The FDA completed an inspection of S&B Pharma LLC d.b.a. Norac Pharma on May 22, 2015 in Azusa, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 22, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Azusa, CA (United States)